Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SANOFI-4698/news/Press-Release-New-48-week-frexalimab-phase-2-data-support-potential-for-high-sustained-efficacy-in-46451635/?utm_source=whatsapp&utm_medium=social&utm_campaign=share